Tagged With AstraZeneca

The US is betting on 3 types of coronavirus vaccines, one of which is totally unproven. A diagram shows how they differ.

The UK is hopeful of rolling out a coronavirus vaccine 'soon after Christmas'

AstraZeneca's promise to make no profit from its COVID-19 vaccine during the pandemic could expire before July 2021, newly uncovered documents show

AstraZeneca resumes COVID-19 trial in Japan but still keeps its US trial on pause

US widens safety inquiry into AstraZeneca's coronavirus vaccine

Global stocks slide as France, Spain, and the UK record thousands of new COVID-19 cases

US stock futures rise on China data ahead of upcoming Federal Reserve policy meeting

AstraZeneca COVID-19 vaccine trial suspended in US for at least several more days amid concerns over serious complication

We won't have enough COVID-19 vaccine for everybody until 2024, warns world's largest vaccine producer

Oxford and AstraZeneca are resuming coronavirus vaccine trials after a participant fell ill

AstraZeneca says its coronavirus vaccine could still be available this year, after it paused a crucial trial following an unexpected illness in a participant

Wall Street analysts lay out what the unexpected pause in AstraZeneca's coronavirus vaccine trial could mean for the race to halt the pandemic

AstraZeneca shares slide after its coronavirus vaccine trial is put on hold due to suspected adverse reaction

One of Australia's vaccine frontrunners AstraZeneca has put trials on hold over a 'concerning' adverse reaction

Pfizer CEO defends the idea of companies profiting off coronavirus vaccines

Early data from AstraZeneca and Oxford's coronavirus vaccine shows an immune response

AstraZeneca shares slide even as the company's coronavirus vaccine trial results show 'promise'

The first human data from AstraZeneca and Oxford's coronavirus vaccine shows an immune response, a positive sign the shot might work

The first trials to figure out if coronavirus vaccines work are starting in the US, and scientists are looking for thousands of volunteers. Here's how to sign up.

Pharmaceutical giants have added $51 billion to their market value in 2020 as they scramble to develop a coronavirus vaccine